|
Lotus Pharmaceuticals Receives SFDA Approval to Initiate Phase I Clinical …
PR Newswire (press release) According to IMS Health, a pharmaceutical market research firm, the anti-asthma and chronic obstructive pulmonary disease market in China reached … |
View full post on asthma – Google News